Lobular carcinoma in situ (LCIS) treatment in 741 Oncology clinics worldwide
741 clinics specializing in Oncology providing treatment of Lobular carcinoma in situ (LCIS) Lobular carcinoma in situ (LCIS) is a non-invasive breast cancer confined to the milk-producing lobules. It is not considered a true cancer but increases the risk of developing invasive breast cancer. Regular monitoring and preventive measures are often recommended. disease worldwide.
Sorted by:
Relevance
Rating
Relevance
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Clinics grouping by rating
Clinic with the highest rating of 5 — Berkana clinic in Moscow, Russia and 6 more, clinic with the most reviews number of 35757 — Aster CMI hospital in Bengaluru, India.
With rating 4.0 and over — 273 clinics .
Countries with the highest number of clinics treating the diseases:
Lobular carcinoma in situ (LCIS):
worldwide
757 clinics
India
42 clinics
Brazil
40 clinics
Mexico
34 clinics
Germany
33 clinics
United Kingdom
33 clinics
Related procedures:
Procedures are likely to be used for Lobular carcinoma in situ (LCIS) treatment:
Breast reconstruction after mastectomy,
Double preventive mastectomy,
Lumpectomy,
Needle biopsy,
and
Nipple and areola reconstruction
.